|
|
|
4574 TAIKO PHARMACEUTICAL CO.,LTD.
|
|
| 02/17/2026 12:00 |
Consolidated Financial Results for the Fiscal Year Ended December 31, 2025 (FY2025) |
| 02/13/2026 15:35 |
Notice Concerning FY2025 Consolidated Results Variance,Dividend of Surplus(Resumption),and Reversal of General Reserve |
| 02/13/2026 15:35 |
Consolidated Financial Results for the Fiscal Year Ended December 31, 2025 (Under Japanese GAAP) |
| 02/13/2026 15:35 |
Notice Concerning Partial Amendments to the Articles of Incorporation |
| 11/11/2025 15:30 |
Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending December 31, 2025 (Under Japanese GAAP) |
| 11/11/2025 15:30 |
Notice regarding the formulation of the Medium-Term Management Plan (FY2026-2028) |
| 11/11/2025 15:30 |
Notice Concerning Revisions to the Full-Year Consolidated Earnings Forecast |
| 11/11/2025 15:30 |
Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending December 31, 2025 (FY2025) |
| 08/20/2025 15:30 |
The completion of liquidation of an overseas consolidated subsidiary(recording of extraordinary profit)and revision of consolidated earnings forecast |
| 08/13/2025 12:00 |
Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending December 31, 2025 (FY2025) |
| 08/08/2025 15:30 |
Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending December 31, 2025 (Under Japanese GAAP) |
| 05/09/2025 15:30 |
Consolidated Financial Results for the First Quarter of the Fiscal Year Ending December 31, 2025 (FY2025) |
| 05/09/2025 15:30 |
Consolidated Financial Results for the First Quarter of the Fiscal Year Ending December 31, 2025 (Under Japanese GAAP) |
|